Skip to Content
Print Share

Medications for Melanoma

Other names: Cancer, Melanoma; Malignant Melanoma; Skin Cancer, Melanoma

More

    What is Melanoma:  Malignant melanoma is a cancerous skin tumor of the skin cells that produce pigment (melanin).

    See also: sub-topics

    Medications to treat Melanoma

    The following list of medications are in some way related to, or used in the treatment of this condition.

    Drug name Rx / OTC Pregnancy CSA Alcohol Reviews Rating Popularity
    Opdivo N Add review Rate

    Generic name: nivolumab systemic

    Drug class: Anti-PD-1 monoclonal antibodies

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    Sylatron C N Add review Rate

    Generic name: peginterferon alfa-2b systemic

    Drug class: antineoplastic interferons, antiviral interferons

    For consumers: dosage, interactions, side effects

    For professionals: Prescribing Information

     
    Intron A C N Add review Rate

    Generic name: interferon alfa-2b systemic

    Drug class: antineoplastic interferons

    For consumers: dosage, interactions, side effects

    For professionals: Prescribing Information

     
    Yervoy C N Add review Rate

    Generic name: ipilimumab systemic

    Drug class: anti-CTLA-4 monoclonal antibodies

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    interferon alfa-2b C N 1 review
    10

    Generic name: interferon alfa-2b systemic

    Brand name:  Intron A

    Drug class: antineoplastic interferons

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts

     
    nivolumab N 1 review
    1.0

    Generic name: nivolumab systemic

    Brand name:  Opdivo

    Drug class: Anti-PD-1 monoclonal antibodies

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     
    dacarbazine C N Add review Rate

    Generic name: dacarbazine systemic

    Brand name:  DTIC-Dome

    Drug class: alkylating agents

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

     
    pembrolizumab D N 1 review
    1.0

    Generic name: pembrolizumab systemic

    Brand name:  Keytruda

    Drug class: Anti-PD-1 monoclonal antibodies

    For consumers: dosage, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     
    Proleukin C N Add review Rate

    Generic name: aldesleukin systemic

    Drug class: miscellaneous antineoplastics, interleukins

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    Keytruda D N 1 review
    1.0

    Generic name: pembrolizumab systemic

    Drug class: Anti-PD-1 monoclonal antibodies

    For consumers: dosage, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    aldesleukin C N Add review Rate

    Generic name: aldesleukin systemic

    Brand name:  Proleukin

    Drug class: miscellaneous antineoplastics, interleukins

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     
    DTIC-Dome C N Add review Rate

    Generic name: dacarbazine systemic

    Drug class: alkylating agents

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph

     
    ipilimumab C N Add review Rate

    Generic name: ipilimumab systemic

    Brand name:  Yervoy

    Drug class: anti-CTLA-4 monoclonal antibodies

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     
    temozolomide Off Label D N Add review Rate

    Generic name: temozolomide systemic

    Drug class: alkylating agents

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information

    Off Label: Yes

     
    peginterferon alfa-2b C N Add review Rate

    Generic name: peginterferon alfa-2b systemic

    Brand name:  Sylatron

    Drug class: antineoplastic interferons, antiviral interferons

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts

     
    Imlygic N Add review Rate

    Generic name: talimogene laherparepvec systemic

    Drug class: miscellaneous antineoplastics

    For consumers: dosage, interactions, side effects

    For professionals: AHFS DI Monograph, Prescribing Information

     
    talimogene laherparepvec N Add review Rate

    Generic name: talimogene laherparepvec systemic

    Brand name:  Imlygic

    Drug class: miscellaneous antineoplastics

    For consumers: dosage, interactions, side effects

    For professionals: A-Z Drug Facts, AHFS DI Monograph

     

    Topics under Melanoma

    Learn more about Melanoma

    Micromedex® Care Notes

    Symptoms and treatments

    Mayo Clinic Reference

    Legend

    Off Label This medication may not be approved by the FDA for the treatment of this condition.
    Prescription Only / Over the Counter
    Rx Prescription Only
    OTC Over the Counter
    Rx/OTC Prescription or Over the Counter
    Pregnancy
    A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
    B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
    C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
    D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
    X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
    N FDA has not classified the drug.
    Controlled Substances Act Schedule
    N Is not subject to the Controlled Substances Act.
    1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
    2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
    3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
    4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
    5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
    Alcohol
    X Interacts with Alcohol.

    Browse Drugs by Condition

    A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

    Drugs.com Mobile Apps

    The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. Available for Android and iOS devices.

    Explore Apps
    Hide